The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - 23andMe
Stock and Other Ownership Interests - 23andMe
Travel, Accommodations, Expenses - 23andMe
Safety, efficacy, and PKPD of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced or metastatic ovarian cancer: Results from a multi-center multi-country phase 1/2a expansion cohort.
 
Ali Raza Khaki
Honoraria - HMP; OncLive/MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences (Inst)
Research Funding - 23andMe (Inst); Janssen Oncology (Inst)
(OPTIONAL) Uncompensated Relationships - Janssen; Pfizer/Astellas
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; GlaxoSmithKline; Inhibrx; Medison
Research Funding - 23 and Me; Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; Frontier Therapeutics; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison
 
Scott A. Laurie
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer
Research Funding - 23andMe (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Pfizer
 
Ching-Chang Hwang
Employment - 23andMe
 
Anh N. Diep
Employment - 23andMe
 
Maike Schmidt
Employment - 23andMe; 23andMe (I); Roche; Roche (I)
Stock and Other Ownership Interests - 23andMe; 23andMe (I); Roche; Roche (I)
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics; Roche
 
Roo Vold
Employment - Nurix; QED Therapeutics
 
Sophia Majeed
Employment - 23andMe
Stock and Other Ownership Interests - 23andMe
Travel, Accommodations, Expenses - 23andMe; Jasper Therapeutics
 
Dylan M. Glatt
No Relationships to Disclose
 
Julie Krystal
No Relationships to Disclose